AnswersNow Raises $40M in Series B Funding for Virtual ABA Therapy
AnswersNow did not wake up one morning and decide to “do telehealth.” It was born in Richmond, Virginia at 1717 East Cary Street, in Shockoe Bottom, from two clinicians, Jeff Beck and Adam Dreyfus, who watched families wait six to eighteen months for autism support while being told help was “on the way.” The problem was not intent. It was access. Parents were isolated. Systems were clogged. The support network was broken long before anyone admitted it out loud.
The first version of AnswersNow was not video. It was text. A HIPAA-compliant Slack group where master’s and PhD-level Board-Certified Behavior Analysts answered parents in real time. One adolescent conquered a lifelong fear of automatic toilets through parent-mediated guidance delivered by text alone. From 2017 to 2020, that quiet experiment proved something uncomfortable. Progress does not require forty hours a week. It requires precision, context, and trust.
When COVID froze in-person ABA in place, AnswersNow did not pause. It accelerated. By June 2020, the company launched a proprietary video-enabled tele-ABA platform. By 2021, text support shrank from ninety-five percent of revenue to ten. One-on-one virtual therapy became forty to sixty percent of services. Today, roughly one hundred BCBAs serve more than one thousand children annually, delivering nearly one hundred thousand hours of therapy and caregiver training in 2025 alone.
That execution just earned $40 million in Series B funding led by HealthQuest Capital, with Left Lane Capital and Owl Ventures returning to the table. Total capital now sits near $64.9 million. The thesis is blunt. Autism affects one in thirty-one children. Forty-nine states lack sufficient provider capacity. AnswersNow connects families to clinicians in five days, not a year, while using four to five therapy hours per week instead of thirty-plus. Outcomes improve. Costs drop up to seventy-five percent.
Behind the platform sits proprietary AI that personalizes therapy in real time, automates clinical documentation, and reinforces a parent-mediated model that extends care beyond scheduled sessions. Ninety-six percent of families report meaningful progress within six months. Net Promoter Score stands at eighty-three. Payers including UnitedHealthcare, Aetna, Cigna, Anthem, Blue Cross Blue Shield, and Medicaid now cover it across six states.
Leadership matters here. Jeff Beck as CEO. Adam Dreyfus as Chief Science Officer. Brian Hamilton scaling operations. Morry Belkin building the platform. Jennifer Grasso aligning product and care. Brittany Wierzba driving research rigor. New executives Kristin Peterson, Mason Davis, Tracey Sheahan, and Wayne Li arriving post-Series B with one hundred fifty years of healthcare experience between them.